Medicare launches obesity drug coverage pilot
Statements (7)
- Neutral
Medicare will cover drugs like Wegovy and Zepbound for weight-loss treatments.
- Neutral
Medicare will start covering obesity drugs for the first time.
- Neutral
Medicare will cover weight-loss drugs under a new pilot program.
- Neutral
Medicare will launch a new GLP-1 Bridge program starting July 1, 2026, allowing patients to access weight-loss medications.
- Neutral
Centers for Medicare & Medicaid Services launched a pilot program giving eligible Medicare beneficiaries access to weight loss drugs for $50 a month.
- Neutral
Medicare will begin covering obesity drugs for the first time starting Wednesday.
- Neutral
Medicare is launching a new Bridge demonstration program to provide obesity drug coverage to eligible beneficiaries.